1. Home
  2. AGIO vs EPAC Comparison

AGIO vs EPAC Comparison

Compare AGIO & EPAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agios Pharmaceuticals Inc.

AGIO

Agios Pharmaceuticals Inc.

HOLD

Current Price

$36.36

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Logo Enerpac Tool Group Corp.

EPAC

Enerpac Tool Group Corp.

HOLD

Current Price

$34.67

Market Cap

1.8B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGIO
EPAC
Founded
2007
1910
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
1.8B
IPO Year
2013
1994

Fundamental Metrics

Financial Performance
Metric
AGIO
EPAC
Price
$36.36
$34.67
Analyst Decision
Buy
Buy
Analyst Count
8
2
Target Price
$38.88
$48.00
AVG Volume (30 Days)
1.1M
679.3K
Earning Date
04-29-2026
03-25-2026
Dividend Yield
N/A
0.12%
EPS Growth
N/A
8.97
EPS
N/A
1.24
Revenue
$43,011,000.00
$616,899,000.00
Revenue This Year
$76.75
$5.60
Revenue Next Year
$170.73
$5.56
P/E Ratio
N/A
$27.69
Revenue Growth
N/A
4.65
52 Week Low
$22.24
$32.35
52 Week High
$46.00
$45.00

Technical Indicators

Market Signals
Indicator
AGIO
EPAC
Relative Strength Index (RSI) 47.03 47.92
Support Level $26.71 $33.11
Resistance Level $44.51 $36.30
Average True Range (ATR) 1.85 1.44
MACD -0.87 -0.07
Stochastic Oscillator 13.39 30.73

Price Performance

Historical Comparison
AGIO
EPAC

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236 and others.

About EPAC Enerpac Tool Group Corp.

Enerpac Tool Group Corp provides high-precision hydraulic and mechanical tools, controlled-force products, and heavy lifting solutions. Operating mainly through its Industrial Tools & Services (IT&S) segment, the company designs, manufactures, and distributes branded tools, and offers maintenance, bolting, machining, joint integrity, and equipment rental services across industries such as oil & gas, manufacturing, power generation, and infrastructure. Its key products include hydraulic cylinders, pumps, torque wrenches, and bolt tensioners under the brands ENERPAC and HYDRATIGHT. The company serves customers internationally, with operations in the USA, Australia, Brazil, Germany, Saudi Arabia, the United Kingdom, and other countries, deriving the majority of its revenue from the USA.

Share on Social Networks: